Unique ID issued by UMIN | UMIN000036574 |
---|---|
Receipt number | R000041671 |
Scientific Title | A randomized prospective comparison of programmed intermittent bolus with continuous infusion for ultrasound-guided erector spinae plane block in video-assisted thoracic surgery |
Date of disclosure of the study information | 2019/05/01 |
Last modified on | 2022/04/24 17:06:16 |
A randomized prospective comparison of programmed intermittent bolus with continuous infusion for ultrasound-guided erector spinae plane block in video-assisted thoracic surgery
A randomized prospective study of two different infusion protocol of ultrasound-guided erector spinae plane block
A randomized prospective comparison of programmed intermittent bolus with continuous infusion for ultrasound-guided erector spinae plane block in video-assisted thoracic surgery
A randomized prospective study of two different infusion protocol of ultrasound-guided erector spinae plane block
Japan |
Lung tumor
Chest surgery | Anesthesiology | Adult |
Malignancy
NO
Verifying the difference of anesthetized dermatomes between two different drug infusion protocol for ultrasound-guided erecor spinae plane block in video-assisted thoracic surgery
Efficacy
The number of anesthetized dermatomes
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Active
2
Treatment
Medicine | Device,equipment |
Using programmed intermittent bolus infusion postoperatively
Using continuous infusion postoperatively
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1.Provided written informed consent
2.American Society of Anesthesiologists physical status 1-3
3.Scheduled to undergo complete video-assisted thoracoscopic surgery for lung cancer.
allergy to local anesthetics
BMI>30
age< 20 or >80
Liver function disorder
Renal function disorder (eGFR<50)
History of past ipsilateral thoracotomy
Normally using opioid analgesics
Treated mental or neurological disorders
Allergy to acetaminophen, NSAIDs, and fentanyl.
Difficulty in adequate verbal communication
Thoracotomy with rib cutting or pleurectomy
50
1st name | Taro |
Middle name | |
Last name | Fujitani |
Ehime Prefectural Central Hospital
Department of Anesthesiology and Critical Care
790-0024
83 Kasuga-machi Matsuyama Ehime Japan 790-0024
089-947-1111
suko1231@yahoo.co.jp
1st name | Yasuko |
Middle name | |
Last name | Taketa |
Ehime Prefectural Cenral Hospital
Department of Anesthesia and Critical Care
790-0024
83 Kasuga-machi Matsuyama Ehime Japan 790-0024
089-947-1111
suko1231@yahoo.co.jp
Ehime Prefectural Central Hospital
None
Other
Institutional review board of Ehime Prefectural Central Hospital
83 Kasuga-machi Matsuyama Ehime Japan 790-0024
089-947-1111
suko1231@yahoo.co.jp
NO
2019 | Year | 05 | Month | 01 | Day |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041671
Unpublished
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041671
50
The number of dermatomes desensitized in the midclavicular line was significantly higher in group P than in group C (p<0.001). The amount of rescue morphine consumed in the early postoperative period (0-24h) was significantly lower in group P (p=0.035). No significant difference in postoperative numerical rating scale score was found between the groups.
2021 | Year | 05 | Month | 08 | Day |
we enrolled those with American Society of Anesthesiologists physical status 1-3 who were scheduled to undergo video-assisted lobectomy for lung cancer between June 2019 and March 2020. Patients who met the following criteria were excluded: inability to provide consent, aged <20 or >80 years, body mass index >30 kg/m2, coagulopathy, history of thoracotomy or breast surgery, use of opioid analgesics, mental or neurological disorders, allergy to perioperative medications, bronchial asthma, impaired renal function with estimated glomerular filtration rate <50 mL/min, and scheduled thoracotomy with rib cutting or pleurectomy.
After obtaining written informed consent from the patients, we enrolled the participants.
No adverse events, such as allergy to local anesthetics, pneumothorax, hematoma, or nerve injury during the study period, were observed.
The primary outcome was the number of desensitized dermatomes in the midclavicular line. The secondary outcomes were the number of desensitized dermatomes in the paraspinal, anterior axillary, and parasternal regions; numerical rating scale (NRS) score at rest and during movement; total rescue morphine consumption at 0-24 and 24-48 h postoperatively; and postoperative nausea and vomiting (PONV) frequency.
Main results already published
2019 | Year | 04 | Month | 24 | Day |
2019 | Year | 06 | Month | 13 | Day |
2019 | Year | 06 | Month | 01 | Day |
2020 | Year | 03 | Month | 31 | Day |
At the time of protocol registration, the primary endpoint of this study was "the number of anesthetized dermatomes at 20 hours after the initial administration," but because this time point would be affected by the bolus timing in the PIB group, the measurement time was changed to 21 hours after the initial administration before starting the study. In addition, the description of the endpoints was changed because it was necessary to include data 5 hours after the first dose for statistical analysis.
2019 | Year | 04 | Month | 22 | Day |
2022 | Year | 04 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041671